BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33730354)

  • 1. Non-modified RNA-Based Reprogramming of Human Dermal Fibroblasts into Induced Pluripotent Stem Cells.
    Belviso I; Di Meglio F; Romano V; Montagnani S; Castaldo C
    Methods Mol Biol; 2022; 2454():675-684. PubMed ID: 33730354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming.
    Du Z; Jia L; Wang Y; Wang C; Wen X; Chen J; Zhu Y; Yu D; Zhou L; Chen N; Zhang S; Celik I; Ay F; Gao S; Zhang S; Li W; Hoffman AR; Cui J; Hu JF
    Sci Data; 2018 Nov; 5():180255. PubMed ID: 30457566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of Adult Human Dermal Fibroblasts from Abdominal Skin and Generation of Induced Pluripotent Stem Cells Using a Non-Integrating Method.
    Belviso I; Sacco AM; Romano V; Schonauer F; Nurzynska D; Montagnani S; Di Meglio F; Castaldo C
    J Vis Exp; 2020 Jan; (155):. PubMed ID: 32009646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-irradiation promotes susceptibility to reprogramming to pluripotent state in human fibroblasts.
    Lee SB; Han SH; Kim MJ; Shim S; Shin HY; Lee SJ; Kim HW; Jang WS; Seo S; Jang S; Lee Y; Park S
    Cell Cycle; 2017; 16(21):2119-2127. PubMed ID: 28902577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA-Based Reprogramming Under Xeno-Free and Feeder-Free Conditions.
    Jeriha J; Kolundzic N; Khurana P; Perez-Dominguez A; Ilic D
    Methods Mol Biol; 2022; 2454():665-674. PubMed ID: 32567019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
    Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
    Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming.
    Sacco AM; Belviso I; Romano V; Carfora A; Schonauer F; Nurzynska D; Montagnani S; Di Meglio F; Castaldo C
    J Cell Mol Med; 2019 Jun; 23(6):4256-4268. PubMed ID: 30980516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells.
    Kim YM; Kang YG; Park SH; Han MK; Kim JH; Shin JW; Shin JW
    Stem Cell Res Ther; 2017 Jun; 8(1):139. PubMed ID: 28595633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.
    Mehta A; Verma V; Nandihalli M; Ramachandra CJ; Sequiera GL; Sudibyo Y; Chung Y; Sun W; Shim W
    PLoS One; 2014; 9(7):e103485. PubMed ID: 25068310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Human iPSCs by Reprogramming with the Unmodified Synthetic mRNA.
    Annand RR
    Methods Mol Biol; 2021; 2239():163-174. PubMed ID: 33226619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells.
    McGrath PS; Diette N; Kogut I; Bilousova G
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30531717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
    Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
    Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
    Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
    Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Overview on Promising Somatic Cell Sources Utilized for the Efficient Generation of Induced Pluripotent Stem Cells.
    Ray A; Joshi JM; Sundaravadivelu PK; Raina K; Lenka N; Kaveeshwar V; Thummer RP
    Stem Cell Rev Rep; 2021 Dec; 17(6):1954-1974. PubMed ID: 34100193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming.
    Hu K
    Cells; 2020 Nov; 9(11):. PubMed ID: 33203179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient induction of pluripotent stem cells from menstrual blood.
    Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
    Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of Capra hircus somatic cells and induction of pluripotent stem-like cells.
    Singh A; Singh SK; Kumar M; Sarma DK; Singh S; Verma V
    In Vitro Cell Dev Biol Anim; 2024 Jan; 60(1):3-8. PubMed ID: 38153638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.